Regentis Biomaterials RGNT
NYSE RGNT
$1.50 +0.03 (+2.41%)
As of: Oct 21, 2026 · 3:51 PM EDT

Regentis Biomaterials (RGNT) Debt Ratio (2024 - 2025)

Updated

Regentis Biomaterials' (RGNT) Debt Ratio stood at 0.16 in Q4 2025, down 98.5% from 10.26 a year earlier.

Analysis

Regentis Biomaterials (RGNT) Debt Ratio (2024 - 2025) Analysis & Trends

  • Across earlier years, Debt Ratio came in at 10.26 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Thermo Fisher Scientific 257.99 Bn 237.02 Bn 4.88 Bn 0.38
2 Abbott Laboratories 175.01 Bn 145.44 Bn 7.27 Bn 0.30
3 Danaher 164.93 Bn 148.74 Bn 3.61 Bn 0.29
4 Intuitive Surgical 151.84 Bn 131.26 Bn 1.96 Bn -
5 Medtronic 119.05 Bn 84.30 Bn 6.34 Bn 0.30
6 Stryker 113.89 Bn 100.00 Bn 4.50 Bn 0.31
7 Boston Scientific 65.37 Bn 60.13 Bn 3.85 Bn 0.28
8 Becton Dickinson 53.36 Bn 50.51 Bn 2.32 Bn 0.33
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn 0.04
10 Regentis Biomaterials 852,949.72 852,949.72 - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 0.16
Dec 31, 2024 10.26
API Access

Regentis Biomaterials Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=RGNT&period=max&api_key=YOUR_API_KEY